Clinical

Dataset Information

0

To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Metastatic Colorectal Cancer


ABSTRACT: The Phase IIa of this clinical study, a dose-escalation study of IAH0968 in combination with CAPEOX, is designed for safety and tolerability in subjects with HER2-positive advanced or metastatic solid tumors. Phase IIb/III is an operational seamless adaptive design consisting of two phases. Phase I (Phase IIb) was designed to initially evaluate the efficacy and safety of IAH0968+CAPEOX in HER2-positive subjects with metastatic colorectal cancer, using PFS.

DISEASE(S): Her2 Gene Mutation,Colorectal Neoplasms

PROVIDER: 4145 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2021-04-09 | PXD021865 | Pride
2020-11-18 | GSE161743 | GEO
2011-03-18 | GSE22358 | GEO
2011-03-18 | E-GEOD-22358 | biostudies-arrayexpress
2024-02-29 | GSE243375 | GEO
2018-02-07 | GSE110174 | GEO
| 2391480 | ecrin-mdr-crc
2015-09-08 | E-GEOD-67982 | biostudies-arrayexpress
2015-09-08 | GSE67982 | GEO
| 2257146 | ecrin-mdr-crc